Structural Studies of Nonribosomal Peptide Synthesis
非核糖体肽合成的结构研究
基本信息
- 批准号:10593078
- 负责人:
- 金额:$ 39.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Amino AcidsAnabolismAntibioticsArchitectureBacteriaBindingBiochemicalBiologicalCatalytic DomainCephalosporinsChemicalsCommunicationCyclosporinsEndowmentEnterobactinEnvironmentEnzymesFaceFamilyGene ClusterImmunosuppressive AgentsIndividualLengthMessenger RNAMicrobeModificationMolecularMolecular ConformationMutagensNatural ProductsNutrientOrganismPenicillinsPeptide AntibioticsPeptide SynthesisPharmaceutical PreparationsPharmacologic SubstancePhysical condensationPlayProcessPropertyProteinsRibosomesRoleSiderophoresSignal TransductionStructureTertiary Protein StructureVancomycinVirulenceanti-cancerbeta-Lactamschemical reactionhuman pathogenmycobactinsnatural product derivativenovel therapeuticspeptide natural productspeptide synthasepyoverdinsmall moleculethioesterunnatural amino acids
项目摘要
Microbes produce natural products to thrive in unique environments where they face a wide
range of conditions and competing organisms. These diverse molecules are often unique to
individual species and play roles in cellular communication and signaling, interspecies
competition, nutrient acquisition, and virulence. The ability of natural products to function in
the biological setting make them attractive candidates for the discovery of new pharmaceuticals.
Indeed, roughly two-thirds of small molecule drugs are derived from natural products.
Understanding the biosynthesis of unusual natural products will facilitate the analysis of the
thousands of biosynthetic gene clusters with no known product and may lead to the discovery of
new pharmaceutically active molecules. One family of peptide-based natural products is
produced by the multidomain nonribosomal peptide synthetases (NRPSs). Among the hundreds
of NRPS products are the important peptide antibiotics vancomycin and teixobactin, β-lactam
antibiotics like some penicillins and cephalosporins, the genotoxin colibactin, the
immunosuppressant cyclosporin, as well as bacterial siderophores like enterobactin, pyoverdine,
and mycobactin. NRPSs use a remarkable assembly line architecture; multiple protein domains
are joined in a single protein that can be thousands or tens of thousands of residues in length.
During biosynthesis, amino acid building blocks are covalently loaded onto a carrier domain and
delivered to neighboring catalytic domains for peptide extension and modification. The use of
nonproteinogenic amino acids in a ribosome- and mRNA-independent synthesis, as well as
subsequent chemical modification by auxiliary domains, enables the striking diversity of NRPS
products. We propose to continue our biochemical and structural studies to understand the
molecular basis of NRPS function. We will identify the features that govern the efficient
progression through the NRPS structural cycle to allow the delivery of bound substrates in a
coordinated, efficient process. These studies will determine structures of large, multidomain
enzymes in catalytically relevant conformations to understand features that enable this
structural cycle. We will also examine unusual NRPSs to identify the features that endow NRPS
domains with the ability to perform unexpected chemical reactions. We will examine NRPSs
with undetermined biosynthetic mechanism with a particular focus on unusual catalytic
properties of condensation and thioester domains, and will determine the products of
uncharacterized NRPSs from human pathogens.
微生物产生天然产物,在独特的环境中繁衍生息,它们面临着广泛的挑战
条件和竞争有机体的范围。这些不同的分子通常是独特的,
在细胞通讯和信号传导中发挥作用,
竞争、营养获取和毒性。天然产物的功能,
生物环境使它们成为发现新药物的有吸引力的候选者。
事实上,大约三分之二的小分子药物来自天然产物。
了解不寻常的天然产物的生物合成将有助于分析
成千上万的生物合成基因簇,没有已知的产品,并可能导致发现
新的药物活性分子。一个基于肽的天然产物家族是
由多结构域非核糖体肽合成酶(NRPS)产生。有几百
NRPS产品的主要成分是重要的肽类抗生素万古霉素和替沙菌素,β-内酰胺类抗生素
抗生素,如青霉素和头孢菌素,大肠杆菌素,
免疫抑制剂环孢菌素以及细菌铁载体如肠杆菌素,绿脓菌荧光素,
和分枝杆菌素。NRPS使用一个显着的装配线架构;多个蛋白质结构域
连接在一个单一的蛋白质,可以是数千或数万个残基的长度。
在生物合成过程中,氨基酸结构单元共价负载到载体结构域上,
递送至邻近的催化结构域用于肽延伸和修饰。使用
在核糖体和mRNA非依赖性合成中的非蛋白质氨基酸,以及
随后通过辅助结构域的化学修饰,使NRPS的惊人多样性成为可能
产品.我们建议继续进行生物化学和结构研究,
NRPS功能的分子基础我们将确定管理高效的
通过NRPS结构循环的进展,以允许以一种非结构化的方式递送结合的底物。
协调、高效的过程。这些研究将确定大型多畴
酶在催化相关的构象,以了解功能,使这一点
结构周期我们还将研究不寻常的NRPS,以确定赋予NRPS的功能
具有执行意外化学反应的能力的域。我们将研究NRPS
生物合成机制尚未确定,特别关注异常催化
缩合和硫酯域的性质,并将决定产品的
来自人类病原体的未表征的NRPS。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW M GULICK其他文献
ANDREW M GULICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW M GULICK', 18)}}的其他基金
Structural Studies of Nonribosomal Peptide Synthesis
非核糖体肽合成的结构研究
- 批准号:
10372983 - 财政年份:2020
- 资助金额:
$ 39.56万 - 项目类别:
Development of HTP Assay for Inhibitors of Aerobactin Production
Aerobactin 生产抑制剂的 HTP 检测方法的开发
- 批准号:
9101161 - 财政年份:2016
- 资助金额:
$ 39.56万 - 项目类别:
The Structural Basis for Modular Nonribosomal Peptide Synthesis
模块化非核糖体肽合成的结构基础
- 批准号:
9006608 - 财政年份:2016
- 资助金额:
$ 39.56万 - 项目类别:
The Structural Basis for Modular Nonribosomal Peptide Synthesis
模块化非核糖体肽合成的结构基础
- 批准号:
9802145 - 财政年份:2016
- 资助金额:
$ 39.56万 - 项目类别:
UNDERSTANDING THE ARCHITECTURE OF CHALLENGING MULTI-DOMAIN PROTEINS
了解具有挑战性的多域蛋白质的结构
- 批准号:
8362303 - 财政年份:2011
- 资助金额:
$ 39.56万 - 项目类别:
High Throughput Screening of Inhibitors of Pyoverdine Production
吡维定生产抑制剂的高通量筛选
- 批准号:
8010266 - 财政年份:2010
- 资助金额:
$ 39.56万 - 项目类别:
STRUCTURES OF NON-RIBOSOMAL PEPTIDE SYNTHETASES AND RELATED PROTEINS
非核糖体肽合成酶及相关蛋白质的结构
- 批准号:
8171492 - 财政年份:2010
- 资助金额:
$ 39.56万 - 项目类别:
High Throughput Screening of Inhibitors of Pyoverdine Production
吡维定生产抑制剂的高通量筛选
- 批准号:
8109333 - 财政年份:2010
- 资助金额:
$ 39.56万 - 项目类别:
UNDERSTANDING THE ARCHITECTURE OF CHALLENGING MULTI-DOMAIN PROTEINS
了解具有挑战性的多域蛋白质的结构
- 批准号:
8170304 - 财政年份:2010
- 资助金额:
$ 39.56万 - 项目类别:
STRUCTURE OF PEPTIDE SYNTHETASES AND RELATED ENZYMES
肽合成酶及相关酶的结构
- 批准号:
7925461 - 财政年份:2009
- 资助金额:
$ 39.56万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 39.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 39.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 39.56万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 39.56万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 39.56万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 39.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 39.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 39.56万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 39.56万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 39.56万 - 项目类别:
Discovery Early Career Researcher Award